The Medical Letter on Drugs and Therapeutics
Oxymetazoline Cream (Rhofade) for Rosacea
May 22, 2017 (Issue: 1521)The FDA has approved the selective alpha1A-adrenergic receptor agonist oxymetazoline as a 1% cream (Rhofade – Allergan) for topical treatment of persistent facial erythema of rosacea in adults. Brimonidine, a selective alpha2-adrenergic...more
- Brimonidine gel (Mirvaso) for rosacea. Med Lett Drugs Ther 2013; 55:82.
- National Rosacea Society. Rosacea triggers survey. Available at: www.rosacea.org. Accessed May 11, 2017.
- S Li et al. Alcohol intake and risk of rosacea in US women. J Am Acad Dermatol 2017 April 1 (epub).
- Rosacea treatment update: recommendations from the Global Rosacea Consensus (ROSCO) panel. Br J Dermatol 2017; 176:465.
- Drugs for rosacea. Med Lett Drugs Ther 2016; 58:16.
- Y Asai et al. Canadian clinical practice guidelines for rosacea. J Cutan Med Surg 2016; 20:432.
- LK Oge' et al. Rosacea: diagnosis and treatment. Am Fam Physician 2015; 92:187.
- EJ van Zuuren et al. Interventions for rosacea. Cochrane Database Syst Rev 2015 April 28; (4):CD003262.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.